The effect of LHRH agonist on urinary retentio
Phase 3
- Conditions
- Acute urinary retention in patients with BPH.Enlarged prostate
- Registration Number
- IRCT20170417033489N3
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 78
Inclusion Criteria
The first acute urinary retention
No other treatment
No indication of surgery
Patient's urinary retention is caused by BPH
Minimum age of 50 years
Exclusion Criteria
Informed patient dissatisfaction
History of any heart, liver, kidney, metabolic and seizure diseases
Patients with fever mean T more than 38 degrees Celsius
High PSA levels (above 4) which strengthen suspicion of prostate cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of post voiding residue(PVR). Timepoint: One day after leaving the cathedral. Method of measurement: Ultrasound.;The rate of catheter release in acute urinary retention induced by BPH. Timepoint: One month after drug injection. Method of measurement: No need for re-catheterization.;IPSS Score. Timepoint: Before and one month after drug injection. Method of measurement: IPSS Questionnaire.;The incidence of drug side effects. Timepoint: One month after drug injection. Method of measurement: Ask the patient.
- Secondary Outcome Measures
Name Time Method